Hero image

October 5 2020 Market Update

By on Oct 05 in Economics, Finance, Financial advisors, Market Update, Worth sharing

A Bump in Volatility and Questions Ahead

Stocks moved lower in September as a five-month market winning streak came to an end. The downturn was led by a selloff in technology stocks, which have paced the S&P 500’s recent recovery from its March 2020 low.

Despite the selloff, the stock market posted its strongest two-quarter performance since the second and third quarters of 2009.

As we look ahead to the fourth quarter, we believe the recent resurgence of volatility is likely to stay. The markets face several unknowns, namely rising COVID-19 caseloads,[1] the uncertainty around additional stimulus in Congress, and, of course, the presidential election. In a surprise turn of events, in the early hours of October 2, the White House announced that President Trump has tested positive for COVID-19.[2]

While the news is changing rapidly, we’re keeping the following trends in mind as we head into the fourth quarter.

Technology sector drives volatility

The volatility we saw in September was driven primarily by technology stocks. These stocks had been a significant driver of the recent rally, and a turn in investor sentiment brought them—and thus the major equity indexes—lower.[3]

As we’ve highlighted in recent months, technology has grown to represent a significant percentage of the S&P 500. This implies that any volatility in the sector will likely have a disproportionate impact on the index as a whole, as we saw last month. We expect that this could continue to play an important role in equity volatility going forward.

Rising Coronavirus Cases

After a period of steady declines, the US started to see a rise in the number of reported coronavirus cases last month. Recent data from Johns Hopkins University shows that cases are increasing in more than half of US states.[4]

Should this trend continue, it could have implications for the economic recovery, notably in terms of jobs and potential business closures. From our vantage point, market sentiment is also tied, at least to some extent, to COVID-19 caseload maps.

At the same time, developments around vaccine discovery are positive. Several companies have entered the final stage of clinical trials.[5] While drug discovery and approval are an uncertain process, we may start to see some encouraging news ahead. This could help to buoy market sentiment in the fourth quarter.

Politics May Play a Bigger Role in the Fourth Quarter

The November election is a source of potential volatility. Aside from the more typical pre-election market jitters around who will win, the absence of a clear landslide victory is likely to delay results. This in itself could prompt the “animal spirits” of the markets to come out: as most investors know, markets tend to dislike uncertainty. This could be more pronounced if there are indications of a disorderly or contested process.

Again, the surprise October 2 news that President Trump tested positive for COVID-19 presents another unknown. The result could impact both the last stretch of campaigning and the election itself, though at this writing it is too early to gauge what that impact is likely to be.

With respect to economic stimulus, on October 1 the House of Representatives passed a $2.2 trillion relief package proposed by Democrats, though at this writing it is considered unlikely to pass the Senate.[6] Again, we believe the forthcoming election puts additional uncertainty on the measure.

Looking Ahead—Together

We begin the fourth quarter with multiple questions. With COVID-19 caseloads, economic policy, and the election, a number of factors are in play that could impact markets.

In the uncertainty ahead, we will be focused on maintaining a calm, prudent approach to both markets and the economy—and we encourage you to do the same.

With that in mind, please continue to join us for our informative webinars and keep an eye out for news and information from our team—and, of course, please reach out if you’d like to chat or if you have any questions or concerns that we can help address.

Most importantly, thank you, as always, for your support and trust in our firm. The first three quarters of 2020 have proven to be turbulent not just for markets but for many of our lives, and it is a privilege to help you navigate this unprecedented time.

JSF Financial

 


Securities are offered through Mid Atlantic Capital Corporation (“MACC”) a registered broker dealer, Member FINRA/SIPC.

Investment advice is offered through JSF Financial, LLC, which is not a subsidiary or control affiliate of MACC.

Confidentiality Note: This email communication including all attachments transmitted with it may contain confidential information intended solely for the use of the addressee. If the reader or recipient of this communication is not the intended recipient, or you believe that you have received this communication in error, please notify the sender immediately by return email or by telephone at (323) 866-0833 and PROMPTLY delete this email including all attachments without reading them or saving them in any manner. The unauthorized use, dissemination, distribution, or reproduction of this email, including attachments, is strictly prohibited and may be unlawful.

The information expressed herein are those of JSF Financial, LLC, it does not necessarily reflect the views of Mid Atlantic Capital Corporation (MACC). Neither JSF Financial LLC nor MACC gives tax or legal advice.  All opinions are subject to change without notice.  Neither the information provided, nor any opinion expressed constitutes a solicitation or recommendation for the purchase or sale of any security.  Investing involves risk, including possible loss of principal.  Indexes are unmanaged and cannot be invested in directly. 

Historical data shown represents past performance and does not guarantee comparable future results.  The information and statistical data contained herein were obtained from sources believed to be reliable but in no way are guaranteed by JSF Financial, LLC or MACC as to accuracy or completeness. The information provided is not intended to be a complete analysis of every material fact respecting any strategy.  The examples presented do not take into consideration commissions, tax implications, or other transactions costs, which may significantly affect the economic consequences of a given strategy. Diversification does not ensure a profit or guarantee against loss. Carefully consider the investment objectives, risks, charges and expenses of the trades referenced in this material before investing. 

Asset Allocation and Diversification do not guarantee a profit or protect against a loss.

The Bloomberg Barclays U.S. Aggregate Bond Index measures the investment-grade U.S. dollar-denominated, fixed-rate taxable bond market and includes Treasury securities, government-related and corporate securities, mortgage-backed securities, asset-backed securities and commercial mortgage-backed securities.

The S&P 500 Index is an unmanaged, market value-weighted index of 500 stocks generally representative of the broad stock market.

The MSCI World Index is a broad global equity index that represents large and mid-cap equity performance across 23 developed markets countries and covers approximately 85% of the free float-adjusted market capitalization in each country.

The MSCI Europe Index captures large and mid cap representation across 15 Developed Markets countries in Europe and covers approximately 85% of the free float-adjusted market capitalization across the European Developed Markets equity universe.

The MSCI Emerging Markets Index captures large and mid-cap representation across 26 emerging markets countries and covers approximately 85% of the free float-adjusted market capitalization in each country.

Gross domestic product (GDP) is a monetary measure of the market value of all the final goods and services produced in a specific time period. GDP is the most commonly used measure of economic activity.


[1] https://coronavirus.jhu.edu/data/animated-world-map

[2] https://www.bloomberg.com/news/articles/2020-10-02/trump-s-covid-diagnosis-jolts-white-house-and-his-campaign

[3] https://www.cnbc.com/2020/09/18/barclays-says-market-valuations-at-dotcom-bubble-levels-downgrades-large-tech-stocks.html

[4] https://www.cnbc.com/2020/09/22/coronavirus-live-updates.html

[5] https://www.cnn.com/2020/09/08/health/pfizer-biontech-vaccine-october-intl-grm/index.html

[6] https://www.cnbc.com/2020/10/01/coronavirus-stimulus-update-house-passes-democratic-relief-bill.html

What's trending

view all

Sorry, there is no service at the moment.

Sophisticated planning for personal outcomes.
Contact us and meet your advisor today.

Meet us today
[ctct form="633"]